CRNA platform advances drive up to 60x gene expression and NOK 620M funding
CRNA said its circVec technology achieved up to 60x gene expression in vivo. The company also raised NOK 620 million, securing funding through 2030, and expanded R&D plus 23 collaborations including major pharma.